Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation
Lung Function, Heart Function and Aerobic Capacity in Patients Suffering From Long-term Symptoms Following SARS-CoV2-infection, and the Association With DNA Methylation
Sponsor: Linkoeping University
Listed as NCT04859894, this observational or N/A phase trial focuses on Cardiopulmonary Disease and Covid19 and remains ongoing. Sponsored by Linkoeping University, it has been updated 6 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Oct 2023 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
May 2021 — Nov 2021 [monthly]
Not Yet Recruiting
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Linkoeping University
For direct contact, visit the study record on ClinicalTrials.gov .